The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
The EU is striving for more sustainable farming, but outdated pesticide regulations are hindering the adoption of biocontrol technologies by treating biopesticides like chemical pesticides. Reforming EU legislation could unlock innovation and position Europe as a leader in sustainable farming.
We sat down with Mark Reudink and Andrew Rosato to unpack their insights from FutureNet and explore how RavenStar fits into the future of the telecom industry.
Researchers at Battelle are working to unlock the potential of polymeric nanoparticles (PNPs) to deliver safe, effective therapies for previously untreatable conditions. In this blog, we’ll cover some of the most frequently asked questions about gene therapy and this novel delivery vehicle technology.
Every new therapy, drug or gene-editing technique starts in the lab, with researchers trying to answer a complex question. Will it work? Is it safe? What could go wrong?Microphysiological systems (MPS) could help these researchers answer those question faster and more effectively.
Gene editing therapies are transforming the way complex genetic disorders are treated. The fast-growing field involves correcting or replacing defective genes to treat disease.
Follow along with the latest news, announcement and updates from our Battelle community of solvers.
We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners. By continuing to browse our
site without changing your settings, you are agreeing to accept all cookies on the site.
